Cue Biopharma (CUE) Stock: Buy, Sell, or Hold?
CUE - Cue Biopharma, Inc.
$28.74
0.74 (2.64%)
▲
5d:
+3.87%
30d:
-5.52%
90d:
+6.09%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 18, 2026
0d
Get Alerted When CUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CUE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CUE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CUE is currently trading at $28.74, which is considered fair relative to its 30-day fair value range of $25.40 to $29.86.
Technical Outlook: Technically, CUE is in a uptrend. Immediate support is located at $25.01, while resistance sits at $32.13.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $90.50 (+214.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CUE is in a uptrend. Immediate support is located at $25.01, while resistance sits at $32.13.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $90.50 (+214.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$25.40 -
$29.86
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (51/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 214.9% below Wall St target ($90.50)
- NEUTRAL: Bottoming setup forming (51/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$25.40 -
$29.86
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$25.01
Resistance Level
$32.13
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.21
Wall Street Target
$90.50
(+214.9%)
Revenue Growth (YoY)
166.7%
Share & Embed Analysis
Last updated: September 12, 2026 10:24 PM ET
Data refreshes hourly during market hours. Next update: 11:24 PM
Data refreshes hourly during market hours. Next update: 11:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 56 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 60 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 57 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 55 HOLD |
